Karger Publishers, Dementia and Geriatric Cognitive Disorders, 1-2(38), p. 10-15, 2014
DOI: 10.1159/000357126
Full text: Unavailable
<b><i>Background:</i></b> The cytokine tumor necrosis factor-alpha (TNF-α) is elevated in the blood of Alzheimer's disease (AD) patients. Epigenetic DNA modifications of the TNF-α promoter may account for the observed upregulation. <b><i>Methods:</i></b> We analyzed blood samples of 50 AD patients and 55 controls plus 4 AD and 4 control cortex samples using bisulfite sequencing PCR. <b><i>Results:</i></b> A significant hypomethylation of the TNF-α promoter was found in AD patients' brains but not in their blood. Cortical TNF-α promoter DNA was higher methylated than blood-derived DNA, both in AD patients and controls. <b><i>Conclusion:</i></b> In AD patients, epigenetic mechanisms of TNF-α gene regulation, like aberrant DNA methylation, are not relevant in blood.